Recalls / —
—#158919
Product
BARD MAX-CORE Disposable Core Biopsy Instrument, Product Codes - MC1410, 14 g x 10 cm; MC1616, 16 g x 16 cm; MC1816, 18 g x 16 cm; MC1820, 18 g x 20 cm; MC1825, 18 g x 25 cm. The core needle biopsy device is intended for use in obtaining biopsies from soft tissues.
- FDA product code
- KNW — Instrument, Biopsy
- Device class
- Class 2
- Medical specialty
- Gastroenterology, Urology
- 510(k) numbers
- K133948
- Affected lot / code info
- Lot Numbers: REBP0019, REBN0342, REBN2123, REBP1199, REBP1419, REBP1807, REBQ0084, REBQ0343, REBQ1012, REBP1420, REBP1809, REBP0869, REBP1266, REBP1267, REBP1421, REBP1422, REBP1810, REBQ0087, REBQ0088, REBQ0347, REBQ0811, REBQ1014, REBP0158, REBQ1904, REBQ1898, REBQ1978, REBR0468, REBQ2296, REBR0474
Why it was recalled
During the review of May 2017 complaint data, a significant increase in MAX-CORE Disposable Core Biopsy Instrument complaints was observed for Failure to Prime, Failure to Fire, Failure to Obtain Sample, and Self-Activation.
Root cause (FDA determination)
Device Design
Action the firm took
BPV sent a customer recall letter on September 22, 2017 to each of the US consignees via FedEx with proof of delivery notification. BPV will also initiate a recall for product outside the US in accordance with regulations of each country in which the product was distributed.
Recalling firm
- Firm
- Bard Peripheral Vascular Inc
- Address
- 1625 W 3rd St, Bldg 1, Tempe, Arizona 85281-2438
Distribution
- Distribution pattern
- US, Australia, Canada, Europe, Middle East, Africa, Latin America, Asia Pacific
Timeline
- Recall initiated
- 2017-09-22
- Terminated
- 2018-09-27
- Status
- —
Source: openFDA Device Recall endpoint. Recall record ID #158919. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.